Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 04-2016 | 01-2016 | 10-2015 | 07-2015 | 04-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,480 | 6,781 | 6,130 | 1,396 | 2,530 |
| Receivables | 68 | 106 | 93 | 189 | 86 |
| Inventories | 320 | 237 | 219 | 207 | 207 |
| TOTAL | $6,180 | $7,212 | $6,592 | $1,979 | $2,856 |
| Non-Current Assets | |||||
| PPE Net | 407 | 231 | 83 | 90 | 97 |
| Intangibles | 1,021 | 1,110 | 1,152 | 1,192 | 1,227 |
| TOTAL | $1,428 | $1,341 | $1,235 | $1,282 | $1,324 |
| Total Assets | $7,608 | $8,553 | $7,827 | $3,261 | $4,180 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 522 | 582 | 384 | 560 | 533 |
| Accrued Expenses | 174 | 201 | 177 | 246 | 160 |
| Other current liabilities | 9,846 | 17,667 | 7,023 | 63 | 70 |
| TOTAL | $10,542 | $18,450 | $7,584 | $869 | $763 |
| Non-Current Liabilities | |||||
| TOTAL | $5 | $7 | $8 | $9 | $10 |
| Total Liabilities | $10,547 | $18,457 | $7,592 | $878 | $773 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,647 | 61,596 | 59,656 | 55,193 | 41,115 |
| Common Shares | 622 | 602 | 553 | 420 | 412 |
| Retained earnings | -102,540 | -102,570 | -91,668 | -88,848 | -86,982 |
| TOTAL | $-2,939 | $-9,904 | $235 | $2,383 | $3,407 |
| Total Liabilities And Equity | $7,608 | $8,553 | $7,827 | $3,261 | $4,180 |